ING Groep N.V (OTC: INGVF). Holds a 7.05% beneficial ownership position in Tenax Therapeutics, Inc. (NASDAQ: TENX), equal to 2,639,666 common shares (2.64 million). The ownership statement identifies ING Capital Markets LLC as the entity holding the position and classifies the stake as passive.
Frontier (NASDAQ: ULCC) Airlines, the wholly owned subsidiary, also expects the aircraft changes to maintain similar capacity with fewer aircraft.
The company said theCapitalraise and listing change support its next phase of CuMo project development.
MiniMed Group’s first-quarter net sales rose 16.6% as reported and 15.8% organically to $843 million, with U.S. growth accelerating and international sales continuing to expand. The company raised fiscal 2027 organicRevenuegrowth guidance to approximately 10.5%, while maintaining adjusted EBITDAMarginguidance of approximately 16%.Key HighlightsMiniMed submitted …
Sphera Funds Management Ltd. holds 1,993,496 shares of Tenax Therapeutics, Inc. (NASDAQ: TENX), representing 5.33% of its common stock. The position is reported on a passive basis, with the reporting parties certifying that the securities were not acquired or held to change or influence …
Verekitug Trials Set Broad Enrollment
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) completed its merger with Vertex Pharmaceuticals, converting each eligible share of common stock into the right to receive $85.00 in cash. Crinetics continued as the surviving corporation and became a wholly ownedSubsidiaryof Vertex. The transaction took effect on September …
iSHARES TRUST (NYSE: SHV) approved the changes on August 6, 2026, and also approved corresponding changes for ISCB.
Advisors' Inner Circle Fund II appoints Markus Hansen as a portfolio manager of the Vontobel International Equity Active ETF effective September 1, 2026. The supplement adds his name and position to the fund’s portfolio-manager information.
Humana Inc. (NYSE: HUM) intends to reaffirm FY 2026 guidance of at least $6.52 in diluted GAAP earnings per common share during meetings with investors and analysts. The company also intends to reaffirm adjusted EPS guidance of at least $9.00 for the year ending …